Food and Drug Administration

FDA Vaccine and Related Biologicals Advisory Committee

Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria CRM₁₉₇ Protein) Prevnar

May 21, 2002

Slides

Indication for Otitis Media Disease  ppt

FinOM Efficacy Trial of 7-Valent Pneumococcal Conjugate Vaccine, Terhi Kilpi, NPHI, Finland   ppt

Results from the Kaiser Permanente Efficacy Trial, Dr. Steven Black, MD, et al., Kaiser Permanente  ppt

Efficacy Against Otitis Media, Dr. George Siber, MDCM  ppt

Prevnar^tm, Pneumococcal Conjugate Vaccine 7-Valent, for the Prevention of Acute Otitis Media, Dr R. Douglas Pratt, MD, MPH  ppt

Lymerix^® Lyme Disease Vaccine (Recombinant Osp A), Dr. Patricia Rohan MD  ppt